查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451343

2024-2032 年痤疮药物市场报告（依痤疮类型、药物类别、药物类型、给药途径和地区）

Acne Drugs Market Report by Acne Type, Drug Class, Drug Type, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球痤疮药物市场规模达到69亿美元。展望未来， IMARC Group预计到2032年市场规模将达到109亿美元，2024-2032年复合年增长率（CAGR）为5.2%。青少年和成人痤疮盛行率的增加、人们对护肤的认识和重视不断增强、医药研发的进步带来了创新疗法、新兴经济体可支配收入的增加以及社交媒体对护肤趋势的影响，这些都促进了市场的成长。

痤疮药物是一种专门用于控制和缓解痤疮症状的药物或非处方 (OTC) 产品，痤疮是一种常见的皮肤病，其特征是存在丘疹、黑头、白头和发炎。这些药物在护肤行业中至关重要，并且是寻求缓解痤疮相关问题的个人的主要资源。痤疮药物的优点包括能够减少发炎、疏通毛孔、控製油脂产生，并最终促进皮肤更洁净、更健康。它们为寻求管理和改善皮肤状况的个人提供了宝贵的资源，强调了这些治疗在皮肤病学和皮肤护理领域的重要性。治疗痤疮的药物有多种类型，主要分为外用治疗和口服治疗。外用药物通常以乳膏、凝胶或乳液的形式出现，直接涂在受影响的皮肤上。另一方面，口服药物被摄取并在体内发挥作用来对抗痤疮。

全球痤疮药物市场受到全球青少年和成人痤疮盛行率日益上升的影响。人们对护肤和外观的认识和重视程度不断提高，进一步支持了这一点。此外，药物研发的进步导致创新和更有效的痤疮药物配方的推出，有助于市场扩张。此外，新兴经济体可支配收入水准的上升使消费者有能力投资痤疮治疗产品，这反过来又促进了市场成长。此外，社群媒体和名人对护肤品代言的影响正在刺激市场成长。除此之外，不断扩大的化妆品行业和个人化护肤解决方案的趋势正在加速市场成长。

痤疮药物市场趋势/驱动因素：

痤疮患病率增加

由于全球青少年和成人痤疮盛行率不断上升，全球痤疮药物市场正在大幅增长。痤疮是一种常见的皮肤病，其特征是形成丘疹、黑头和白头，影响全球数百万人。痤疮病例激增主要归因于多种因素，包括青春期荷尔蒙变化、压力水平增加以及不良饮食和护肤习惯等生活方式因素。因此，对有效的痤疮治疗方案的需求不断增长，以解决这一广泛的问题。这个驱动因素凸显了製药公司迫切需要开发和提供创新、可靠且易于使用的痤疮药物，以满足不同患者群体的需求，从而推动全球痤疮药物市场的成长。

人们对护肤的认识与重视程度不断提高

全球痤疮药物市场的另一个关键驱动力是人们对护肤和个人外表的认识和重视不断增强。在当今注重形象的社会中，人们越来越倾向于投资护肤产品和治疗，以获得洁净无瑕的肌肤。这种意识的提高是由社群媒体的影响所推动的，在社群媒体上，无瑕的皮肤经常被描绘成理想的标准。因此，消费者更加主动地寻求管理和治疗痤疮的解决方案。市场受益于对痤疮药物和治疗的需求增加，因为个人愿意探索各种产品和疗法来增强皮肤的健康和外观，从而促进市场的强劲成长。

药物研究与开发的进展

全球痤疮药物市场受到药物研发（R＆D）不断进步的显着推动。製药公司正在积极开发创新且更有效的痤疮治疗配方。这些进步涵盖各个方面，包括新型活性成分的发现、改进的药物传输系统以及针对痤疮病理生理学多个方面的联合疗法的开发。这些创新导致更安全、更有效、见效更快的痤疮药物的推出，最终满足患者不断变化的需求。此外，副作用较少的外用和口服药物的开发证明了研发工作所取得的进展。因此，这些创新透过为医疗保健专业人员和患者提供有效管理痤疮的优质治疗选择来推动市场成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球痤疮药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按痤疮类型

  • 粉刺性
    • 市场走向
    • 市场预测
  • 发炎
    • 市场走向
    • 市场预测
  • 囊性
    • 市场走向
    • 市场预测
  • 手术后/伤口
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依药物类别

  • 类维生素A
    • 市场走向
    • 市场预测
  • 抗生素
    • 市场走向
    • 市场预测
  • 荷尔蒙剂
    • 市场走向
    • 市场预测
  • 复方药物
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依药物类型

  • 非处方药
    • 市场走向
    • 市场预测
  • 处方药
    • 市场走向
    • 市场预测

第 9 章：市场区隔：依管理途径

  • 专题
    • 市场走向
    • 市场预测
  • 口服
    • 市场走向
    • 市场预测
  • 可注射
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allergan Plc
    • Bausch Health Companies Inc.
    • Bayer Aktiengesellschaft
    • Cipher Pharmaceuticals Inc.
    • Galderma Holding SA
    • Johnson & Johnson
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Skinvisible Pharmaceuticals Inc.
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A2359

The global acne drugs market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. Increasing prevalence of acne among adolescents and adults, growing awareness and emphasis on skincare, advancements in pharmaceutical R&D leading to innovative treatments, rising disposable incomes in emerging economies, and social media influence on skincare trends are facilitating the market growth.

Acne drugs are pharmaceutical or over-the-counter (OTC) products specifically designed to manage and alleviate the symptoms of acne, a common skin condition characterized by the presence of pimples, blackheads, whiteheads, and inflammation. These medications are pivotal in the skincare industry and serve as a primary resource for individuals seeking relief from acne-related concerns. Advantages of acne drugs include their ability to reduce inflammation, unclog pores, control oil production, and ultimately promote clearer, healthier skin. They offer a valuable resource for individuals seeking to manage and improve their skin condition, underlining the significance of these treatments in the realm of dermatology and skincare. There are various types of acne drugs available, primarily categorized into topical and oral treatments. Topical medications typically come in the form of creams, gels, or lotions and are applied directly to the affected skin. On the other hand, oral medications are ingested and work internally to combat acne.

The global acne drugs market is influenced by the increasing prevalence of acne among adolescents and adults worldwide. This is further supported by the growing awareness and emphasis on skincare and appearance. Moreover, advancements in pharmaceutical research and development, leading to the introduction of innovative and more efficient acne drug formulations, contribute to market expansion. Additionally, the rise in disposable income levels in emerging economies empowers consumers to invest in acne treatment products, which, in turn, is augmenting the market growth. Furthermore, the influence of social media and celebrity endorsements of skincare products is stimulating the market growth. Apart from this, the expanding cosmetic industry and the trend towards personalized skincare solutions are accelerating the market growth.

Acne Drugs Market Trends/Drivers:

Increasing prevalence of acne

The global acne drugs market is witnessing a substantial surge due to the escalating prevalence of acne among adolescents and adults worldwide. Acne, a common skin condition characterized by the formation of pimples, blackheads, and whiteheads, affects millions of individuals across the globe. This surge in acne cases is primarily attributed to various factors, including hormonal changes during puberty, increased stress levels, and lifestyle factors such as poor diet and inadequate skincare routines. As a result, there is a growing demand for effective acne treatment options to address this widespread concern. This driver underscores the urgent need for pharmaceutical companies to develop and provide innovative, reliable, and accessible acne medications that cater to diverse patient populations, thereby fueling the growth of the global acne drugs market.

Growing awareness and emphasis on skincare

Another critical driver of the global acne drugs market is the growing awareness and emphasis on skincare and personal appearance. In today's image-conscious society, individuals are increasingly inclined to invest in skincare products and treatments to achieve clear and blemish-free skin. This heightened awareness is driven by the influence of social media, where flawless skin is often portrayed as an ideal standard. As a result, consumers are more proactive in seeking solutions to manage and treat acne. The market benefits from this heightened demand for acne drugs and treatments, as individuals are willing to explore a wide range of products and therapies to enhance their skin's health and appearance, thus contributing to the market's robust growth.

Advancements in pharmaceutical research and development

The global acne drugs market is significantly propelled by continuous advancements in pharmaceutical research and development (R&D). Pharmaceutical companies are actively engaged in developing innovative and more efficient formulations for acne treatment. These advancements encompass various aspects, including the discovery of novel active ingredients, improved drug delivery systems, and the development of combination therapies that target multiple aspects of acne's pathophysiology. Such innovations result in the introduction of safer, more effective, and faster-acting acne drugs, ultimately meeting the evolving needs of patients. Furthermore, the development of topical and oral medications with fewer side effects is a testament to the progress made in R&D efforts. Consequently, these innovations drive market growth by providing healthcare professionals and patients with superior treatment options for managing acne effectively.

Acne Drugs Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global acne drugs market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on acne type, drug class, drug type, and route of administration.

Breakup by Acne Type:

Comedonal

Inflammatory

Cystic

Postsurgical/Wound

A detailed breakup and analysis of the market based on the acne type has been provided in the report. This includes comedonal, inflammatory, cystic, and postsurgical/wound.

For the comedonal segment, key drivers include the surging prevalence of non-inflammatory acne cases, rising awareness among individuals regarding mild acne treatment, increased accessibility to over-the-counter remedies, pharmaceutical companies' focus on targeted solutions, and the pursuit of clear, blemish-free skin. In the Inflammatory segment, drivers encompass the demand for potent anti-inflammatory agents, growing cases of moderate to severe acne, continuous research efforts to develop effective solutions, dermatologist recommendations, and the influence of social media on seeking medical-grade treatments. Cystic acne's drivers revolve around its severity, leading to a higher demand for prescription-based medications, the need for specialized treatments, increased patient awareness, emerging innovative therapies, and the aspiration to prevent scarring. Postsurgical/wound acne treatment segment is driven by factors such as the need for post-procedure skincare, the rise in cosmetic surgeries, scar prevention, dermatologist prescriptions, and the emphasis on post-surgical recovery and aesthetics.

Breakup by Drug Class:

Retinoids

Antibiotics

Hormonal Agents

Combination Drugs

Others

Retinoids dominate the market

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes retinoids, antibiotics, hormonal agents, combination drugs, and others. According to the report, retinoids represented the largest segment.

The retinoids segment within the global acne drugs market is driven by the surging awareness regarding the advantages of retinoids in acne treatment. Their efficacy lies in their ability to regulate skin cell turnover, prevent the formation of comedones (blackheads and whiteheads), and reduce inflammation. This proven track record makes retinoids a go-to choice for both healthcare professionals and individuals seeking reliable acne solutions. Furthermore, retinoids have garnered widespread dermatologist endorsement, underlining their credibility and medical backing. Dermatologists often prescribe retinoids, either in topical or oral form, for various acne types, especially for moderate to severe cases. Another driving factor is the continuous innovation in retinoid formulations. Pharmaceutical companies are investing in research and development to enhance the tolerability and effectiveness of retinoid-based treatments, reducing side effects commonly associated with them. Moreover, the demand for retinoids extends beyond acne treatment, as they are also recognized for their anti-aging properties, further expanding their market reach. This dual functionality appeals to a broader consumer base.

Breakup by Drug Type:

OTC Drugs

Prescription Drugs

A detailed breakup and analysis of the market based on the drug type has also been provided in the report. This includes OTC drugs and prescription drugs.

Over-the-counter (OTC) drugs segment are witnessing substantial growth, driven by their easy accessibility and the increasing preference for self-care solutions. Consumers appreciate the convenience of obtaining these medications without prescriptions, enabling them to manage mild to moderate acne independently. The growing trend of self-care further bolsters their popularity, with individuals seeking swift remedies for common skin concerns, readily available at pharmacies, supermarkets, and online outlets. On the other hand, the prescription drugs segment thrives on dermatologist recommendations and the severity of acne cases. Dermatologists, recognized authorities in skin conditions, frequently prescribe potent, tailored medications for moderate to severe acne cases. This professional endorsement significantly influences patients' choices, directing them towards prescription drugs. These specialized formulations are designed to address specific skin issues effectively. As a result, the demand for prescription-based solutions remains robust, contributing significantly to the growth of this segment.

Breakup by Route of Administration:

Topical

Oral

Injectable

Topical holds the largest share in the market

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes topical, oral, and injectable. According to the report, topical represented the largest segment.

The topical segment within the global acne drugs market is driven by the convenience of topical treatments plays a significant role, as these products are easy to apply directly to affected areas, making them a preferred choice for many individuals seeking localized acne management. Moreover, the efficacy and safety of topicals have improved over the years, thanks to continuous advancements in pharmaceutical research and development, leading to formulations with fewer side effects and better outcomes. In line with this, dermatologist recommendations heavily influence the topical segment, as medical professionals often prescribe specific topical medications tailored to a patient's unique skin condition. Furthermore, the broad range of topicals available, including creams, gels, and lotions, provides options that cater to various skin types and preferences. Additionally, the accessibility of over-the-counter (OTC) topical acne treatments contributes to the segment's growth, enabling individuals to address mild to moderate acne issues independently. Apart from this, the increasing awareness of skincare and the desire for clear, blemish-free skin further propel the demand for topical acne treatments, emphasizing their integral role in the global market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest acne drugs market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's acne drugs market is influenced by several key factors, including the region's high prevalence of acne among adolescents and adults, underlining the demand for effective treatments. Furthermore, advanced healthcare infrastructure and accessibility to dermatologists and medical professionals enhance diagnosis and prescription of acne medications. In line with this, a robust consumer inclination towards skincare and appearance maintenance contributes to market growth. This is further supported by the prevalence of a well-established cosmetic and pharmaceutical industry, which fosters innovation and product development in the acne drugs sector. Moreover, awareness campaigns and skincare education initiatives play a crucial role in creating a proactive approach toward acne management. Additionally, regulatory support and stringent quality standards in North America ensure the safety and efficacy of acne drugs, further bolstering consumer trust in the market.

Competitive Landscape:

The competitive landscape of the global acne drugs market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative and effective solutions for acne treatment. While specific players are not mentioned here due to the user's request, it's important to note that the market fosters competition through research and development, strategic collaborations, and product diversification. Companies within this space are continually investing in R&D to formulate new medications and therapies that target various types of acne, ranging from mild to severe cases. Partnerships with dermatologists and skincare experts help in endorsing their products, adding credibility and market reach. Furthermore, marketing strategies, including digital marketing and social media, play a pivotal role in promoting their products and educating consumers about effective acne management. The competitive landscape emphasizes the importance of quality, safety, and innovation in addressing the diverse needs of individuals seeking acne treatments, ultimately benefiting consumers with a wider range of options and improved solutions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Allergan Plc

Bausch Health Companies Inc.

Bayer Aktiengesellschaft

Cipher Pharmaceuticals Inc.

Galderma Holding SA

Johnson & Johnson

Pfizer Inc.

Reckitt Benckiser Group Plc

Skinvisible Pharmaceuticals Inc.

Sun Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In May 2023, Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for investigational IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) Gel with a Prescription Drug User Fee Act (PDUFA).

In June 2023, Sun Pharmaceutical Industries Ltd, received approval of Health Canada, the country's health regulator, for its WINLEVI cream, used in treating certain skin ailments.

In September 2023, Marksans Pharma completed the acquisition of Teva Pharmaceuticals in India to continue providing an uninterrupted supply of Teva's important medicines to customers and patients.

Key Questions Answered in This Report

  • 1. How big is the global acne drugs market?
  • 2. What is the expected growth rate of the global acne drugs market during 2024-2032?
  • 3. What are the key factors driving the global acne drugs market?
  • 4. What has been the impact of COVID-19 on the global acne drugs market?
  • 5. What is the breakup of the global acne drugs market based on the drug class?
  • 6. What is the breakup of the global acne drugs market based on the route of administration?
  • 7. What are the key regions in the global acne drugs market?
  • 8. Who are the key players/companies in the global acne drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Acne Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Acne Type

  • 6.1 Comedonal
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Inflammatory
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cystic
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Postsurgical/Wound
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Retinoids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Antibiotics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hormonal Agents
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Drug Type

  • 8.1 OTC Drugs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Prescription Drugs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Topical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cipher Pharmaceuticals Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Galderma Holding SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Reckitt Benckiser Group Plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Skinvisible Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sun Pharmaceutical Industries Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Acne Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Acne Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Acne Drugs Market: Breakup by Acne Type (in %), 2023
  • Figure 4: Global: Acne Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Acne Drugs Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Acne Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Acne Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Acne Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Acne Drugs (Comedonal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Acne Drugs (Comedonal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Acne Drugs (Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Acne Drugs (Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Acne Drugs (Cystic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Acne Drugs (Cystic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Acne Drugs (Postsurgical/Wound) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Acne Drugs (Postsurgical/Wound) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Acne Drugs (Retinoids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Acne Drugs (Retinoids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Acne Drugs (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Acne Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Acne Drugs (Hormonal Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Acne Drugs (Hormonal Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Acne Drugs (Combination Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Acne Drugs (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Acne Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Acne Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Acne Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Acne Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Acne Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Acne Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Acne Drugs (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Acne Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Acne Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Acne Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Acne Drugs (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Acne Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia Pacific: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia Pacific: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Acne Drugs Industry: SWOT Analysis
  • Figure 86: Global: Acne Drugs Industry: Value Chain Analysis
  • Figure 87: Global: Acne Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Acne Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Acne Drugs Market Forecast: Breakup by Acne Type (in Million US$), 2024-2032
  • Table 3: Global: Acne Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 4: Global: Acne Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 5: Global: Acne Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 6: Global: Acne Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Acne Drugs Market Structure
  • Table 8: Global: Acne Drugs Market: Key Players